Tasso announced today that the FDA cleared its Tasso+ lancet blood collection system as a Class II medical device. Seattle-based Tasso designed its device for single-use, patient-centric blood collection. It provides a simple, virtually painless blood collection experience. The company said in a news release that Tasso+ is the first device of its kind to […]
Tasso
Tasso lands $6m to launch home blood-collection device
Blood-collection startup Tasso said it has completed a $6.1 million financing round led by Vertical Venture Partners (VVP), with participation from Techstars and Cedars-Sinai. The funding will help Tasso scale its first product, Tasso OnDemand, which enables self-collection of blood samples, and to add personnel to support commercial growth. Tasso OnDemand allows people to collect blood at home […]
DreaMed inks licensing deal for artificial pancreas technology with Medtronic | Medtech funding for the week of April 6, 2015
Tasso, GenTegra win DARPA grant for blood-draw tech
Tasso said it won a $2.9 million grant from the U.S. Defense Advanced Research Projects Agency to continue work on an integrated blood-sampling device that can be used in war zones.
The grant to Tasso and development partner GenTegra was awarded based on progress the companies have made under a previously issued Phase II SBIR contract, Madison, Wis.-based Tasso said.